The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Solid Dosage Contract Manufacturing Market Research Report 2024
Synopsis
The pharmaceuticals solid dosage contract manufacturing comes under the category of the pharmaceutical formulations. It is the largest segment of all the type of the pharmaceutical formulation outsourcing.
The global Pharmaceutical Solid Dosage Contract Manufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Solid Dosage Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Solid Dosage Contract Manufacturing.
Report Scope
The Pharmaceutical Solid Dosage Contract Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Solid Dosage Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Solid Dosage Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Catalent Pharma Solutions
Jubilant Life Sciences Limited
Alkermes
BioPharma Solutions
Cytovance Biologics
DPT Laboratories
Fresenius Kabi
Halo Pharmaceutical
Lyophilization Technology
Mikart
Pillar5 Pharma
Haupt Pharma
Althea Technologies
Associates of Cape Cod
Covance
Emergent BioSolutions
Segment by Type
Tablets
Capsule
Lozenge
Powder
Others
Segment by Application
Instant Release
Sustained Release
Extended Release
Effervescent Tablets
Chewable Tablets
Enteric Release
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Solid Dosage Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The pharmaceuticals solid dosage contract manufacturing comes under the category of the pharmaceutical formulations. It is the largest segment of all the type of the pharmaceutical formulation outsourcing.
The global Pharmaceutical Solid Dosage Contract Manufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Solid Dosage Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Solid Dosage Contract Manufacturing.
Report Scope
The Pharmaceutical Solid Dosage Contract Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Solid Dosage Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Solid Dosage Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Catalent Pharma Solutions
Jubilant Life Sciences Limited
Alkermes
BioPharma Solutions
Cytovance Biologics
DPT Laboratories
Fresenius Kabi
Halo Pharmaceutical
Lyophilization Technology
Mikart
Pillar5 Pharma
Haupt Pharma
Althea Technologies
Associates of Cape Cod
Covance
Emergent BioSolutions
Segment by Type
Tablets
Capsule
Lozenge
Powder
Others
Segment by Application
Instant Release
Sustained Release
Extended Release
Effervescent Tablets
Chewable Tablets
Enteric Release
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Solid Dosage Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Lozenge
1.2.5 Powder
1.2.6 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Instant Release
1.3.3 Sustained Release
1.3.4 Extended Release
1.3.5 Effervescent Tablets
1.3.6 Chewable Tablets
1.3.7 Enteric Release
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Perspective (2019-2030)
2.2 Pharmaceutical Solid Dosage Contract Manufacturing Growth Trends by Region
2.2.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Solid Dosage Contract Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Solid Dosage Contract Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Solid Dosage Contract Manufacturing Market Dynamics
2.3.1 Pharmaceutical Solid Dosage Contract Manufacturing Industry Trends
2.3.2 Pharmaceutical Solid Dosage Contract Manufacturing Market Drivers
2.3.3 Pharmaceutical Solid Dosage Contract Manufacturing Market Challenges
2.3.4 Pharmaceutical Solid Dosage Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Solid Dosage Contract Manufacturing Players by Revenue
3.1.1 Global Top Pharmaceutical Solid Dosage Contract Manufacturing Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Solid Dosage Contract Manufacturing Revenue
3.4 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Concentration Ratio
3.4.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Solid Dosage Contract Manufacturing Revenue in 2023
3.5 Pharmaceutical Solid Dosage Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Solid Dosage Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Pharmaceutical Solid Dosage Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Solid Dosage Contract Manufacturing Breakdown Data by Type
4.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Solid Dosage Contract Manufacturing Breakdown Data by Application
5.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2019-2030)
6.2 North America Pharmaceutical Solid Dosage Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2019-2030)
7.2 Europe Pharmaceutical Solid Dosage Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2019-2030)
9.2 Latin America Pharmaceutical Solid Dosage Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.1.4 Abbott Laboratories Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Catalent Pharma Solutions
11.2.1 Catalent Pharma Solutions Company Detail
11.2.2 Catalent Pharma Solutions Business Overview
11.2.3 Catalent Pharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.2.4 Catalent Pharma Solutions Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.2.5 Catalent Pharma Solutions Recent Development
11.3 Jubilant Life Sciences Limited
11.3.1 Jubilant Life Sciences Limited Company Detail
11.3.2 Jubilant Life Sciences Limited Business Overview
11.3.3 Jubilant Life Sciences Limited Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.3.4 Jubilant Life Sciences Limited Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.3.5 Jubilant Life Sciences Limited Recent Development
11.4 Alkermes
11.4.1 Alkermes Company Detail
11.4.2 Alkermes Business Overview
11.4.3 Alkermes Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.4.4 Alkermes Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.4.5 Alkermes Recent Development
11.5 BioPharma Solutions
11.5.1 BioPharma Solutions Company Detail
11.5.2 BioPharma Solutions Business Overview
11.5.3 BioPharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.5.4 BioPharma Solutions Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.5.5 BioPharma Solutions Recent Development
11.6 Cytovance Biologics
11.6.1 Cytovance Biologics Company Detail
11.6.2 Cytovance Biologics Business Overview
11.6.3 Cytovance Biologics Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.6.4 Cytovance Biologics Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.6.5 Cytovance Biologics Recent Development
11.7 DPT Laboratories
11.7.1 DPT Laboratories Company Detail
11.7.2 DPT Laboratories Business Overview
11.7.3 DPT Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.7.4 DPT Laboratories Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.7.5 DPT Laboratories Recent Development
11.8 Fresenius Kabi
11.8.1 Fresenius Kabi Company Detail
11.8.2 Fresenius Kabi Business Overview
11.8.3 Fresenius Kabi Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.8.4 Fresenius Kabi Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.8.5 Fresenius Kabi Recent Development
11.9 Halo Pharmaceutical
11.9.1 Halo Pharmaceutical Company Detail
11.9.2 Halo Pharmaceutical Business Overview
11.9.3 Halo Pharmaceutical Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.9.4 Halo Pharmaceutical Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.9.5 Halo Pharmaceutical Recent Development
11.10 Lyophilization Technology
11.10.1 Lyophilization Technology Company Detail
11.10.2 Lyophilization Technology Business Overview
11.10.3 Lyophilization Technology Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.10.4 Lyophilization Technology Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.10.5 Lyophilization Technology Recent Development
11.11 Mikart
11.11.1 Mikart Company Detail
11.11.2 Mikart Business Overview
11.11.3 Mikart Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.11.4 Mikart Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.11.5 Mikart Recent Development
11.12 Pillar5 Pharma
11.12.1 Pillar5 Pharma Company Detail
11.12.2 Pillar5 Pharma Business Overview
11.12.3 Pillar5 Pharma Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.12.4 Pillar5 Pharma Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.12.5 Pillar5 Pharma Recent Development
11.13 Haupt Pharma
11.13.1 Haupt Pharma Company Detail
11.13.2 Haupt Pharma Business Overview
11.13.3 Haupt Pharma Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.13.4 Haupt Pharma Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.13.5 Haupt Pharma Recent Development
11.14 Althea Technologies
11.14.1 Althea Technologies Company Detail
11.14.2 Althea Technologies Business Overview
11.14.3 Althea Technologies Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.14.4 Althea Technologies Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.14.5 Althea Technologies Recent Development
11.15 Associates of Cape Cod
11.15.1 Associates of Cape Cod Company Detail
11.15.2 Associates of Cape Cod Business Overview
11.15.3 Associates of Cape Cod Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.15.4 Associates of Cape Cod Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.15.5 Associates of Cape Cod Recent Development
11.16 Covance
11.16.1 Covance Company Detail
11.16.2 Covance Business Overview
11.16.3 Covance Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.16.4 Covance Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.16.5 Covance Recent Development
11.17 Emergent BioSolutions
11.17.1 Emergent BioSolutions Company Detail
11.17.2 Emergent BioSolutions Business Overview
11.17.3 Emergent BioSolutions Pharmaceutical Solid Dosage Contract Manufacturing Introduction
11.17.4 Emergent BioSolutions Revenue in Pharmaceutical Solid Dosage Contract Manufacturing Business (2019-2024)
11.17.5 Emergent BioSolutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
